Journal Home
Search for

Volume 19, Issue 3, Pages 209-213 (May 2008)


View previous. 12 of 22 View next.

Classical cardiovascular risk factors according to fasting plasma glucose levels

Sergio Martinez-HervasaCorresponding Author Informationemail address, Pedro Romerob, Enrique B. Hevillac, José T. Reala, Antonia Priegoa, Jose M. Martin-Morenoc, Rafael Carmenaa, Juan F. Ascasoa

Received 24 April 2007; received in revised form 29 June 2007; accepted 27 September 2007. published online 09 November 2007.

Abstract 

Background

To compare the prevalence of classical cardiovascular risk factors (CVRF) and metabolic syndrome (MetS) in our population according to fasting plasma glucose levels (FPG).

Methods

We have studied 344 subjects between 20–70 years of age, recruited in a Primary Care Clinic. Subjects were divided into four groups according to their fasting plasma glucose (FPG) values: normal plasma glucose (NG) when FPG<5.6 mmol/L; FPG between 5.6 and 6.0 mmol/L (FPG1); FPG between 6.1–6.9 mmol/L (FPG2); and diabetes (DM) FPG7 mmol/L or previous diagnosis of diabetes. Cardiovascular risk factors (hypertension, TC/HDL-C index and Apo B values), presence of the MetS and indirect measure of insulin resistance (HOMA) were analyzed.

Results

Subjects with FPG2 have a prevalence of classic CVRF and MetS similar to that observed in subjects with type 2 diabetes mellitus (T2DM). The TC:HDL-C index5 in 56% and 57%, Apo B1.2 g/L in 59% and 57%, hypertension in 60% and 54% of FPG2 and T2DM subjects, respectively. MetS was diagnosed in 79% of FPG2 and 80% of T2DM. We found significant differences with FPG1 group who presented low CVRF and MetS proportion.

Conclusion

In our population FPG2 and T2DM subjects show a similar cardiovascular risk profile. On the other hand, such risk is significantly lower in subjects with FPG between 5.6–6.0 mmol/L. These results might have practical implications.

a Endocrinology Service, University Clinical Hospital, Department of Medicine—University of Valencia, Spain

b Center for Primary Care, Valencia, Spain

c Department of Preventive Medicine and Public Health, University of Valencia & University Clinical Hospital, Valencia, Spain

Corresponding Author InformationCorresponding author. S. Endocrinología, Hospital Clínico Universitario de Valencia, Avda Blasco Ibanez 17, 46010 Valencia, Spain. Tel.: +34 96 3862665; fax: +34 96 3862665.

PII: S0953-6205(07)00264-6

doi:10.1016/j.ejim.2007.09.005


View previous. 12 of 22 View next.